NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/03/2023
Back to search
Official data from USPTO
LONG GROVE PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
LONG GROVE PHARMACEUTICALS
ST13
US500000097029073Class
5, 35
Filing
97029073
Registration
7183846
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
10/03/2023
Classification
Registered
Trademark type
Word
Nice classes
5, 35
Filing date
09/15/2021
Registration date
10/03/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/03/2023
Last transaction
10/03/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/19/2019
First use in commerce
06/19/2019
Drawing code
4
Owner type
16
Owner location
Rosemont, IL
Examiner
HA, PAULINE
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Long Grove Pharmaceuticals, LLC
Representatives
Claudia Ray KIRKLAND & ELLIS LLP
Technical classification
Nice Classes
Class 5Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the treatment of skin conditions and uterine hemorrhage in humans
Class 35
Providing wholesale ordering and buying services featuring pharmaceutical goods to third party service providers
Publications
History of USPTO decisions and trademark events.
32 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/03/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/30/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/29/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/21/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/21/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/22/2023
GNFR
FINAL REFUSAL E-MAILED
05/22/2023
CNFR
SU - FINAL REFUSAL - WRITTEN
05/22/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/05/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/28/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/28/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/31/2022
GNRT
NON-FINAL ACTION E-MAILED
10/31/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
10/31/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/18/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/18/2022
IUAF
USE AMENDMENT FILED
10/03/2022
EISU
TEAS STATEMENT OF USE RECEIVED
10/03/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/26/2022
PUBO
PUBLISHED FOR OPPOSITION
07/26/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/23/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/23/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/23/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/23/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/23/2022
DOCK
ASSIGNED TO EXAMINER
06/17/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/21/2021
NWAP
NEW APPLICATION ENTERED
09/18/2021
Continuous trademark protection
Get notified about every new filing that threatens LONG GROVE PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.